Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Research and Development Expenses

v3.8.0.1
Research and Development Expenses
 12 Months Ended
Dec. 31, 2017
Research And Development Expenses  
RESEARCH AND DEVELOPMENT EXPENSES
NOTE 13:- RESEARCH AND DEVELOPMENT EXPENSES

 

      Year ended December 31,  
      2017     2016     2015  
      NIS in thousands  
                     
  Clinical and preclinical trials     13,710       19,504       10,815  
  Salary and related expenses     3,150       2,546       2,575  
  Patents     830       759       842  
  Royalties     39       42       240  
  Laboratory materials     227       144       190  
  Rent     182       181       182  
  Depreciation     12       15       19  
  Others     172       189       189  
                           
        18,322       23,380       15,052